A new preprint describes the significant variation in the early immune response elicited by two of the earliest vaccines to gain emergency authorization against coronavirus...
-360x180.jpg)
Researchers in the Republic of Korea have conducted a study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome encodes for four structural proteins, of which include the nucleocapsid (N), spike (S), membrane (M), and...
Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged, multiple variants of concern (VOCs) have arisen. These variants of concern show enhanced infectivity, immune evasion,...
During the second coronavirus disease 2019 (COVID-19) wave in Brazil, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 (Gamma) lineage has accounted for most...
The current worldwide outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has wreaked devastating economic and social...
The emergence of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led the scientific community and pharmaceutical...
Please can you introduce yourself and tell us what inspired your recent research into the treatment of severe spinal cord injuries? I am Samuel Stupp,...
A new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) known as the Omicron (B.1.1.529) variant was first identified in South Africa...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the virus responsible for the coronavirus disease 2019 (COVID-19), has been circulating around the world...
In a recent study posted to the bioRxiv* pre-print server, a team of researchers demonstrated the neutralization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
_on_a_T-cell_is_binding_to_a_molecule_on_a_cancer_-_Alpha_Tauri_3D_Graphics_M1_dc8762afeaee4937ad644739f274c7a5-620x480-360x180.jpg)
Today saw the launch of a dedicated grant program aimed at advancing therapeutic discovery for follicular lymphoma (FL), The Follicular Lymphoma Foundation (FLF) CURE FL...
